Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
This Bitcoin-focused microcap is building a treasury strategy centered on accumulating BTC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Cell Source Inc (PK) CLCS

Healthcare Biotechnology
Cell Source, Inc., a biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance. Its lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. The company’s Veto Cell technology is used in various applications, including treatment of... see more

Recent & Breaking News (PINL:CLCS)

Cell Source Announces Closing of Private Placement and Hiring of Transfer Agent

ACCESS Newswire January 15, 2026

Cell Source Presents Potential Breakthrough in the Development of Off-the-Shelf CAR-T Cell Therapy at American Society of Hematology Annual Meeting

ACCESS Newswire December 19, 2024

Cell Source Shares Promising Interim Results From Groundbreaking Veto Cell Clinical Trial

ACCESS Newswire November 21, 2024

Darlene Soave Joins Cell Source's Board of Directors

PR Newswire April 1, 2021

USPTO Issues New Patents for Cell Source's Veto Cell Technology

PR Newswire March 19, 2021

Veto T-Cell Bone Marrow Transplant Safely Demonstrates Potential Cure for Sickle Cell Anemia in Preclinical Trials

PR Newswire March 12, 2021

Pediatric Stem Cell Transplantation Expert and Industry Leader Dr. Joseph Rosenthal Joins Cell Source's Scientific Advisory Board

PR Newswire February 25, 2021

Cell Source to Present at the LD Micro Main Event

ACCESS Newswire November 25, 2015

Cell Source to Present at the LD Micro Main Event

ACCESS Newswire November 25, 2015

Cell Source's Megadose Drug Combination Treats First Patient

Marketwired November 11, 2015

Inaugural Scientific Advisory Board Summit JV Pharma Collaboration Initiative

Marketwired November 4, 2015

Cell Source Appoints Dr. Hermann Einsele to Its Scientific Advisory Board

Marketwired September 2, 2015

Cell Source Appoints Dr. Dennis Brown as Chairman of Its Board of Directors

Marketwired August 19, 2015

Cell Source Appoints Dr. Robert Negrin to Its Scientific Advisory Board

Marketwired July 6, 2015

Cell Source Appoints Dr. Steven Burakoff to Its Scientific Advisory Board

Marketwired June 29, 2015

World Class Immunologist Dr. Herman Waldmann Joins Cell Source's Scientific Advisory Board

Marketwired June 17, 2015

Cell Source Appoints Dr. Terry Strom as Chairman of Its Scientific Advisory Board

Marketwired June 4, 2015

Cell Source to Present at the 2015 Marcum MicroCap Conference

Marketwired May 22, 2015

Cell Source, Inc. Announces the Launch of Its New Investor Relations Website

Marketwired May 22, 2015

Cell Source Retains Strategic Patent Advisor Dr. Michael B. Farber

ACCESS Newswire May 20, 2015

Podcasts